Rapid Micro Biosystems, Inc.
RPID · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $7,838 | $7,262 | $7,205 | $8,218 |
| % Growth | 7.9% | 0.8% | -12.3% | – |
| Cost of Goods Sold | $5,563 | $5,315 | $6,801 | $7,237 |
| Gross Profit | $2,275 | $1,947 | $404 | $981 |
| % Margin | 29% | 26.8% | 5.6% | 11.9% |
| R&D Expenses | $3,529 | $3,230 | $3,624 | $3,402 |
| G&A Expenses | $5,644 | $6,079 | $5,690 | $4,826 |
| SG&A Expenses | $8,539 | $9,193 | $8,441 | $7,808 |
| Sales & Mktg Exp. | $2,895 | $3,114 | $2,751 | $2,982 |
| Other Operating Expenses | $1,579 | $1,672 | $0 | $0 |
| Operating Expenses | $13,647 | $14,095 | $12,065 | $11,210 |
| Operating Income | -$11,372 | -$12,148 | -$11,661 | -$10,229 |
| % Margin | -145.1% | -167.3% | -161.8% | -124.5% |
| Other Income/Exp. Net | -$125 | $301 | $405 | $554 |
| Pre-Tax Income | -$11,497 | -$11,847 | -$11,256 | -$9,675 |
| Tax Expense | $8 | $11 | $7 | -$9 |
| Net Income | -$11,505 | -$11,858 | -$11,263 | -$9,666 |
| % Margin | -146.8% | -163.3% | -156.3% | -117.6% |
| EPS | -0.25 | -0.27 | -0.26 | -0.22 |
| % Growth | 7.4% | -3.8% | -18.2% | – |
| EPS Diluted | -0.25 | -0.27 | -0.26 | -0.22 |
| Weighted Avg Shares Out | 44,535 | 44,649 | 43,993 | 43,769 |
| Weighted Avg Shares Out Dil | 44,535 | 44,649 | 43,993 | 43,769 |
| Supplemental Information | – | – | – | – |
| Interest Income | $371 | $351 | $466 | $575 |
| Interest Expense | $417 | $0 | $0 | $0 |
| Depreciation & Amortization | $804 | $811 | $847 | $869 |
| EBITDA | -$10,276 | -$11,036 | -$10,814 | -$9,360 |
| % Margin | -131.1% | -152% | -150.1% | -113.9% |